Goldenwell Biotech, Inc. / Fundamentals
Income statement
- Net revenue
€32.17K - Cost of goods sold
-€62.89 - Gross profit
€32.23K - SG&A expenses
€99.09K - R&D expenses
€0.00 - EBITDA
-€64.17K - D&A
€0.00 - EBIT
-€66.85K - Interest expenses
€3.62K - EBT
-€77.71K - Tax expenses
€0.00 - Net income
-€77.71K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€64.70K - Changes in working capital
€73.23 - Operating cash flow
-€12.93K - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€56.69K - Other financing cash flow
€51.69K - Net financing cash flow
€56.69K - Foreign exchange effects
€0.00 - Net change in cash
€43.76K - Cash at end of period
€65.91K - Free cash flow
-€12.93K
Balance sheet
- Cash and cash equivalents
€65.91K - Cash and short-term investments
€65.91K - Total receivables
€0.00 - Inventory
€150.59K - Other current assets
€0.00 - Total current assets
€216.50K - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€216.50K - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€53.85K - Total current liabilities
€55.45K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€235.87K - Total non-current liabilities
€235.87K - Total liabilities
€291.32K - Common stock
€8.53K - Retained earnings
-€1.21M - Other equity
€0.00 - Total equity
-€74.82K - Total liabilities and shareholders' equity
€216.50K
Company information
- Market capitalization
€16.89M - Employees
3 - Enterprise Value
€19.85M
Company ratios
- Gross margin
-
100.2% Much better than peer group: 20.1% - EBITDA margin
-
-199.4% Much better than peer group: -9,309.0% - EBIT margin
-
-207.8% Much better than peer group: -22,266.9% - EBT margin
-
-241.5% Much better than peer group: -50,747.1% - Net margin
-
-241.5% Much better than peer group: -57,629.7% - ROE
-
103.9% Much worse than peer group: 1,773,146,403,988,663.3% - ROA
-
-35.9% Much better than peer group: -75,436.2% - Asset turnover
-
14.9% Much worse than peer group: 476.6% - FCF margin
-
-40.2% Much better than peer group: -1,189.9% - FCF yield
-0.1% - Efficiency ratio
299.4% - Net sales per employee
-
€10.72K - Net income per employee
-
-€25.90K